These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8658630)

  • 1. Plasma endothelin levels in the early period after renal transplantation.
    Xiao XR; Ao JH; Li YT; Zhang XY; Zeng Q; Yu XJ
    Transplant Proc; 1996 Jun; 28(3):1212-4. PubMed ID: 8658630
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of misoprostol on renal function and plasma endothelin-1 levels during early postoperative stage of living donor renal transplant recipients.
    Kim HJ; Kwak JY
    Transplant Proc; 1996 Jun; 28(3):1207-9. PubMed ID: 8658628
    [No Abstract]   [Full Text] [Related]  

  • 3. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA; Levi M; IJzermans JN; ten Cate JW; Weimar W
    Transplant Proc; 1999; 31(1-2):329. PubMed ID: 10083130
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma nitric oxide in patients with renal transplants].
    Zeng Q; Xiao X; Zhang X
    Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):687-9. PubMed ID: 8731916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of delayed kidney graft function: role of endothelin-1, thromboxane B2, and leukotriene B4.
    Schilling M; Holzinger F; Friess H; Seiler C; Büchler MW
    Transplant Proc; 1996 Feb; 28(1):304-5. PubMed ID: 8644233
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ
    Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary thromboxane B2 and cyclic AMP in cyclosporine-A-treated kidney transplantation.
    Quereda C; Sabater J; Villafruela J; Revalderia JG; Marcen R; Ortuño J
    Transplant Proc; 1994 Oct; 26(5):2604-5. PubMed ID: 7940810
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
    Neumayer HH; Färber L; Budde K; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
    Transplant Proc; 1996 Aug; 28(4):2207-13. PubMed ID: 8769202
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequency of recurrent lupus nephritis among ninety-seven renal transplant patients during the cyclosporine era.
    Stone JH; Millward CL; Olson JL; Amend WJ; Criswell LA
    Arthritis Rheum; 1998 Apr; 41(4):678-86. PubMed ID: 9550477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival.
    Ahn MS; Ha J; Yun IJ; Kim S; Lee JS; Kim S; Han JS; Ahn C; Choi Y; Cheong HI; Kim ST; Kim SJ
    Transplant Proc; 1996 Jun; 28(3):1316-7. PubMed ID: 8658675
    [No Abstract]   [Full Text] [Related]  

  • 11. Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation.
    Vamvakas S; Bahner U; Becker P; Steinle A; Götz R; Heidland A
    Transplant Proc; 1996 Dec; 28(6):3468-73. PubMed ID: 8962350
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients.
    Tsang WK; Ho YW; Tong KL; Chan WH; Chan A
    Transplant Proc; 1996 Jun; 28(3):1330-2. PubMed ID: 8658681
    [No Abstract]   [Full Text] [Related]  

  • 13. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.
    Domínguez J; Fuenzalida D; Norambuena R; Pais E; Cortes Monroy G; Llanos R
    Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin plasma levels in acute graft rejection after heart transplantation.
    Dengler TJ; Zimmermann R; Tiefenbacher CP; Braun K; Sack FU; Kübler W
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1057-64. PubMed ID: 8719451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case study: de novo application of Neoral in renal transplantation.
    Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2189-91; discussion 2192, 2195. PubMed ID: 8769196
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine increases endothelin-1 plasma levels in renal transplant recipients.
    Cauduro RL; Costa C; Lhulier F; Garcia RG; Cabral RD; Gonçalves LE; Manfro RC
    Transplant Proc; 2004 May; 36(4):880-1. PubMed ID: 15194301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicardipine on blood cyclosporine levels in renal transplant patients.
    Guan D; Wang R; Lu J; Wang M; Xu C
    Transplant Proc; 1996 Jun; 28(3):1311-2. PubMed ID: 8658673
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.
    Schiavelli R; Sgrosso JL; Sabbatiello R; Castro C; Ahualli L; Pattin M; Vazquez MC
    Transplant Proc; 1996 Dec; 28(6):3343-4. PubMed ID: 8962299
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.